282 related articles for article (PubMed ID: 23293752)
1. Therapeutic Modalities in Diabetic Nephropathy: Future Approaches.
Reeves WB; Rawal BB; Abdel-Rahman EM; Awad AS
Open J Nephrol; 2012 Jun; 2(2):5-18. PubMed ID: 23293752
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.
Abdel-Rahman EM; Saadulla L; Reeves WB; Awad AS
J Gen Intern Med; 2012 Apr; 27(4):458-68. PubMed ID: 22005942
[TBL] [Abstract][Full Text] [Related]
4. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
Lai PB; Zhang L; Yang LY
Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
[TBL] [Abstract][Full Text] [Related]
5. TGF-Beta as a Master Regulator of Diabetic Nephropathy.
Wang L; Wang HL; Liu TT; Lan HY
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360646
[TBL] [Abstract][Full Text] [Related]
6. Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges.
ElGamal H; Munusamy S
Protein Pept Lett; 2017; 24(1):71-77. PubMed ID: 27894247
[TBL] [Abstract][Full Text] [Related]
7. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
[TBL] [Abstract][Full Text] [Related]
8. A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition.
Tuttle KR; Anderson PW
Am J Kidney Dis; 2003 Sep; 42(3):456-65. PubMed ID: 12955673
[TBL] [Abstract][Full Text] [Related]
9. Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-β1-connective tissue growth factor signalling cascade.
Huang J; Matavelli LC; Siragy HM
Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):215-21. PubMed ID: 21265872
[TBL] [Abstract][Full Text] [Related]
10. Connective tissue growth factor antagonizes transforming growth factor-β1/Smad signalling in renal mesangial cells.
O'Donovan HC; Hickey F; Brazil DP; Kavanagh DH; Oliver N; Martin F; Godson C; Crean J
Biochem J; 2012 Jan; 441(1):499-510. PubMed ID: 21871016
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of diabetic nephropathy.
Raptis AE; Viberti G
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S424-37. PubMed ID: 11460589
[TBL] [Abstract][Full Text] [Related]
12. Kidney involvement and disease in patients with diabetes.
Chiarelli F; Trotta D; Verrotti A; Mohn A
Panminerva Med; 2003 Mar; 45(1):23-41. PubMed ID: 12682618
[TBL] [Abstract][Full Text] [Related]
13. [Importance of diabetic nephropathy in childhood. Clinical findings and basic research in recent decades].
Fekete A; Vannay Á
Orv Hetil; 2014 Jan; 155(4):141-50. PubMed ID: 24440726
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway.
Zhou G; Li C; Cai L
Am J Pathol; 2004 Dec; 165(6):2033-43. PubMed ID: 15579446
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
Wang S; Denichilo M; Brubaker C; Hirschberg R
Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
[TBL] [Abstract][Full Text] [Related]
16. Effects of vitamin D on renal fibrosis in diabetic nephropathy model rats.
Tian Y; Lv G; Yang Y; Zhang Y; Yu R; Zhu J; Xiao L; Zhu J
Int J Clin Exp Pathol; 2014; 7(6):3028-37. PubMed ID: 25031721
[TBL] [Abstract][Full Text] [Related]
17. Diabetic nephropathy: where hemodynamics meets metabolism.
Forbes JM; Fukami K; Cooper ME
Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
[TBL] [Abstract][Full Text] [Related]
18. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
Guha M; Xu ZG; Tung D; Lanting L; Natarajan R
FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073
[TBL] [Abstract][Full Text] [Related]
19. Improvements in the Management of Diabetic Nephropathy.
Dounousi E; Duni A; Leivaditis K; Vaios V; Eleftheriadis T; Liakopoulos V
Rev Diabet Stud; 2015; 12(1-2):119-33. PubMed ID: 26676665
[TBL] [Abstract][Full Text] [Related]
20. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.
Makino H; Mukoyama M; Sugawara A; Mori K; Suganami T; Yahata K; Fujinaga Y; Yokoi H; Tanaka I; Nakao K
Clin Exp Nephrol; 2003 Mar; 7(1):33-40. PubMed ID: 14586741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
